Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
iShares Core S&P 500 ETF
IVV
$902B
| $662K | ﹤0.01% |
2,562
-2,402
| -48% | -$736K |
|
|
EGRX
527
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $659K | ﹤0.01% |
14,336
| – | – |
|
528
L3Harris
LHX
$53.4B
| $646K | ﹤0.01% |
3,587
-326
| -8% | -$66.8K |
|
529
Post Holdings
POST
$3.57B
| $643K | ﹤0.01% |
11,840
-534
| -4% | -$34.7K |
|
|
MCHB
530
Mechanics Bancorp
MCHB
$3.68B
| $626K | ﹤0.01% |
28,140
-6,560
| -19% | -$190K |
|
531
Enanta Pharmaceuticals
ENTA
$400M
| $623K | ﹤0.01% |
12,121
+29
| +0.2% | +$1.55K |
|
532
CF Industries
CF
$17.3B
| $613K | ﹤0.01% |
22,553
-1,716
| -7% | -$63.7K |
|
533
Steel Dynamics
STLD
$37.6B
| $608K | ﹤0.01% |
26,990
-2,849
| -10% | -$78K |
|
534
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.6B
| $607K | ﹤0.01% |
+12,841
| New | +$549K |
|
535
Camden Property Trust
CPT
$11.3B
| $587K | ﹤0.01% |
7,410
+1,723
| +30% | +$179K |
|
536
Collegium Pharmaceutical
COLL
$956M
| $584K | ﹤0.01% |
35,744
| – | – |
|
537
Evercore
EVR
$11.8B
| $582K | ﹤0.01% |
12,632
-36
| -0.3% | -$2.41K |
|
538
Southern Company
SO
$107B
| $581K | ﹤0.01% |
10,736
-5,017
| -32% | -$318K |
|
539
Vanguard Information Technology ETF
VGT
$149B
| $581K | ﹤0.01% |
21,952
-1,608
| -7% | -$48.7K |
|
540
Duke Energy
DUK
$97.3B
| $558K | ﹤0.01% |
6,902
+903
| +15% | +$82.9K |
|
|
JPN
541
DELISTED
Xtrackers Japan JPX-Nikkei 400 Equity ETF
JPN
| $555K | ﹤0.01% |
23,160
+10,211
| +79% | +$273K |
|
|
HOLX
542
DELISTED
Hologic
HOLX
| $549K | ﹤0.01% |
15,628
-65
| -0.4% | -$3.1K |
|
|
SNP
543
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $549K | ﹤0.01% |
11,263
+1,295
| +13% | +$68.8K |
|
544
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
| $530K | ﹤0.01% |
6,181
-1,115
| -15% | -$107K |
|
545
Blackstone
BX
$110B
| $523K | ﹤0.01% |
+11,474
| New | +$635K |
|
546
Mondelez International
MDLZ
$79.9B
| $521K | ﹤0.01% |
10,405
-881
| -8% | -$47.7K |
|
547
British American Tobacco
BTI
$128B
| $513K | ﹤0.01% |
15,004
-302
| -2% | -$12.3K |
|
548
iShares Core S&P Mid-Cap ETF
IJH
$127B
| $508K | ﹤0.01% |
+17,660
| New | +$657K |
|
|
CHX
549
DELISTED
ChampionX
CHX
| $487K | ﹤0.01% |
+84,664
| New | +$1.76M |
|
550
Workday
WDAY
$44.4B
| $484K | ﹤0.01% |
3,716
+2,279
| +159% | +$384K |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.